Advocacy & Awareness

Upcoming Advocacy Events & Calls to Action

Voice of the Patient Report

On May 1, 2024, the beginning of PWS Awareness Month, we announced the release of the Voice of the Patient Report. This timely filing marks a significant moment for the Prader-Willi syndrome community! The report gives crucial insights that amplify the perspective of individuals and families affected by PWS and sheds light on aspects of PWS that may not be fully captured in drug trials alone. Integrating the patient’s voice throughout the drug approval process for PWS treatments is essential for the U.S. Food and Drug Administration’s (FDA) comprehensive understanding and impactful decision-making. 

The Voice of the Patient Report was created following the June 2023 PWS Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting and is compiled of testimonials shared during the EL-PFDD meeting, as well as those submitted virtually.

PWSA | USA, FPWR, and IPWSO extend heartfelt gratitude to the entire PWS community for contributing to the success of this project. To truly amplify the patient’s voice, our entire community must commit to ongoing advocacy efforts. This entails incorporating patient perspectives into all facets of processes and systems, ensuring genuine and enduring change. It’s not solely about isolated advocacy initiatives—it’s about steadfast dedication to embracing and elevating the voices of those directly affected by Prader-Willi syndrome.

You can read the Voice of the Patient Report by clicking the button below.

Find your Representative

PWS State Qualifier Campaign

We are excited to share that several new community members are in the beginning stages of having PWS added to their state’s list of developmental disabilities.

PWS State Qualifier Campaign Map

If you or someone you know is interested in leading the charge in your state, please email PWSA | USA at Advocacy@pwsausa.org.

Meet some of PWSA | USA’s advocates

PWSA | USA's Advocacy in Action Webinar

Check Out PWSA | USA'S
PWS Awareness Month Hub

A Big Step Forward
EL-PFDD Meeting

Your voice made a difference! PWS’s First Externally Led Patient-Focused Drug Development Meeting was a success. We have officially filed the Voice of the Patient Report, which is a document put together to include the stories shared during the meeting and submitted virtually. Click the button below to find the report and to learn more about the EL-PFDD.

Promising Pathway Act

Send an email to your officials with one click!

VISIT OUR BLOG

Rare Disease Advocates Will Unite in Washington, D.C., to Celebrate National Prader-Willi Syndrome (PWS) Awareness Month, National PWS Awareness Day

Rare Disease Advocates Will Unite in Washington, D.C., to Celebrate National Prader-Willi Syndrome (PWS) Awareness Month, National PWS Awareness Day

May 8, 2024 (Washington, D.C.) — Prepare for a powerful convergence in the heart of Washington, D.C., on May 15th as advocates for individuals living with Prader-Willi syndrome (PWS) gather for PWSA | USA’s important advocacy event, the D.C. Fly-In. This year marks the 2nd National PWS Awareness Day, a significant milestone achieved through the […]

The PWS Voice of the Patient Report has Been Filed with the FDA!

The PWS Voice of the Patient Report has Been Filed with the FDA!

On May 1, 2024, the first day of PWS Awareness Month, the Voice of the Patient Report was officially filed with the FDA! This timely filing marks a significant moment for the Prader-Willi syndrome community. The report gives crucial insights that amplify the perspective of individuals and families affected by PWS and sheds light on […]

Calling All PWS Community Members: Sign the FDA Petition

Calling All PWS Community Members: Sign the FDA Petition

Attention everyone in the Prader-Willi syndrome (PWS) community and beyond! We need your support NOW! We are rallying behind a critical petition urging the FDA to take action on DCCR (diazoxide choline) for individuals living with PWS. Soleno Therapeutics’ investigational drug has shown remarkable promise in improving hyperphagia, reducing fat mass, and addressing challenging PWS-associated […]

Scroll to top